Impact of conflicting information on the use of antirheumatic drugs in pregnancy and breastfeeding: perspectives of healthcare providers from the global PRAISE survey
Background: Treating rheumatic musculoskeletal diseases (RMDs) during pregnancy and breastfeeding presents significant complexities, mainly due to inconsistencies between the clinical guidance documents and the reference safety information, including the summary of product characteristics (SmPC) and...
Saved in:
| Main Authors: | , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
SAGE Publishing
2025-07-01
|
| Series: | Therapeutic Advances in Musculoskeletal Disease |
| Online Access: | https://doi.org/10.1177/1759720X251350087 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1849319038624202752 |
|---|---|
| author | Karen Schreiber Christine Graversgaard Ioannis Parodis Nancy Agmon-Levin Silvia Aguilera Aleksandra Antovic George K. Bertsias Ilaria Bini Anca Bobirca Susana Capela Ricard Cervera Nathalie Costedoat-Chalumeau Radboud Dolhain Oseme Etomi Julia Flint Joao Eurico Fonseca Ruth Fritsch-Stork Frauke Förger Ian Giles Bethan Goulden Carina Götestam Skorpen Iva Gunnarsson Latika Gupta Hege Svean Koksvik Louise Linde Jacob Lykke Yvette Meissner Anna Molto Louise Moore Marta Mosca Catherine Nelson-Piercy Luis Fernando Perez-Garcia Luigi Raio Ane Lilleoere Rom Amihai Rottenstreich Muna Saleh Savino Sciascia Anja Strangfeld Elisabet Svenungsson Maria G. Tektonidou Angela Tincani Anne Troldborg Jelena Vojinovic Anne Voss Marianne Wallenius Nuria Zuniga-Serrano Laura Andreoli |
| author_facet | Karen Schreiber Christine Graversgaard Ioannis Parodis Nancy Agmon-Levin Silvia Aguilera Aleksandra Antovic George K. Bertsias Ilaria Bini Anca Bobirca Susana Capela Ricard Cervera Nathalie Costedoat-Chalumeau Radboud Dolhain Oseme Etomi Julia Flint Joao Eurico Fonseca Ruth Fritsch-Stork Frauke Förger Ian Giles Bethan Goulden Carina Götestam Skorpen Iva Gunnarsson Latika Gupta Hege Svean Koksvik Louise Linde Jacob Lykke Yvette Meissner Anna Molto Louise Moore Marta Mosca Catherine Nelson-Piercy Luis Fernando Perez-Garcia Luigi Raio Ane Lilleoere Rom Amihai Rottenstreich Muna Saleh Savino Sciascia Anja Strangfeld Elisabet Svenungsson Maria G. Tektonidou Angela Tincani Anne Troldborg Jelena Vojinovic Anne Voss Marianne Wallenius Nuria Zuniga-Serrano Laura Andreoli |
| author_sort | Karen Schreiber |
| collection | DOAJ |
| description | Background: Treating rheumatic musculoskeletal diseases (RMDs) during pregnancy and breastfeeding presents significant complexities, mainly due to inconsistencies between the clinical guidance documents and the reference safety information, including the summary of product characteristics (SmPC) and the patient information leaflets (PIL). Objectives: To assess healthcare professionals’ (HCPs) prescribing behaviors, comfort levels, and challenges when advising patients, focusing on discrepancies between clinical guidance documents and SmPC/PIL. Design: Online survey entitled PRAISE (Perception of healthcare providers Regarding Antirheumatics in pregnancy and breastfeeding: advice, Information and patient perSpEctives) and disseminated through HCPs groups and social media. Methods: A cross-sectional survey was conducted among 414 HCPs globally. Respondents were divided into prescribers ( n = 336) and non-prescribers ( n = 78) based on their self-reported role in prescribing antirheumatic medications to pregnant or breastfeeding patients with RMDs. The survey covered demographics, clinical experience, confidence in prescribing, use of clinical guidelines, and experiences managing conflicting information between guidelines and SmPC/PIL. Results: Prescribers were more likely than non-prescribers to feel comfortable discussing medication safety during pregnancy. Most prescribers found clinical guidance documents useful, with 48% rating them as “very useful” and 38% as “extremely useful.” In case of conflicting information between clinical guidance documents and SmPC/PIL, 58% of HCPs reported that it caused confusion and tension in patient–doctor relationships, and almost 20% of them are “likely” or “very likely” to discontinue ongoing treatment. Clear communication and shared decision-making were the most common strategies used to address patient concerns. Conclusion: HCPs often face significant challenges when advising patients with RMDs on the use of medications during pregnancy and breastfeeding. Conflicting information between clinical guidance documents and SmPC/PIL can disrupt patient–doctor relationship and lead to treatment discontinuation, with potential consequences on maternal disease control. Improved alignment between clinical guidance documents and the SmPC/PIL could enhance patient care and prevent confusion among HCPs and patients. |
| format | Article |
| id | doaj-art-6e4d765c4b29498c9f685862d98b40fc |
| institution | Kabale University |
| issn | 1759-7218 |
| language | English |
| publishDate | 2025-07-01 |
| publisher | SAGE Publishing |
| record_format | Article |
| series | Therapeutic Advances in Musculoskeletal Disease |
| spelling | doaj-art-6e4d765c4b29498c9f685862d98b40fc2025-08-20T03:50:39ZengSAGE PublishingTherapeutic Advances in Musculoskeletal Disease1759-72182025-07-011710.1177/1759720X251350087Impact of conflicting information on the use of antirheumatic drugs in pregnancy and breastfeeding: perspectives of healthcare providers from the global PRAISE surveyKaren SchreiberChristine GraversgaardIoannis ParodisNancy Agmon-LevinSilvia AguileraAleksandra AntovicGeorge K. BertsiasIlaria BiniAnca BobircaSusana CapelaRicard CerveraNathalie Costedoat-ChalumeauRadboud DolhainOseme EtomiJulia FlintJoao Eurico FonsecaRuth Fritsch-StorkFrauke FörgerIan GilesBethan GouldenCarina Götestam SkorpenIva GunnarssonLatika GuptaHege Svean KoksvikLouise LindeJacob LykkeYvette MeissnerAnna MoltoLouise MooreMarta MoscaCatherine Nelson-PiercyLuis Fernando Perez-GarciaLuigi RaioAne Lilleoere RomAmihai RottenstreichMuna SalehSavino SciasciaAnja StrangfeldElisabet SvenungssonMaria G. TektonidouAngela TincaniAnne TroldborgJelena VojinovicAnne VossMarianne WalleniusNuria Zuniga-SerranoLaura AndreoliBackground: Treating rheumatic musculoskeletal diseases (RMDs) during pregnancy and breastfeeding presents significant complexities, mainly due to inconsistencies between the clinical guidance documents and the reference safety information, including the summary of product characteristics (SmPC) and the patient information leaflets (PIL). Objectives: To assess healthcare professionals’ (HCPs) prescribing behaviors, comfort levels, and challenges when advising patients, focusing on discrepancies between clinical guidance documents and SmPC/PIL. Design: Online survey entitled PRAISE (Perception of healthcare providers Regarding Antirheumatics in pregnancy and breastfeeding: advice, Information and patient perSpEctives) and disseminated through HCPs groups and social media. Methods: A cross-sectional survey was conducted among 414 HCPs globally. Respondents were divided into prescribers ( n = 336) and non-prescribers ( n = 78) based on their self-reported role in prescribing antirheumatic medications to pregnant or breastfeeding patients with RMDs. The survey covered demographics, clinical experience, confidence in prescribing, use of clinical guidelines, and experiences managing conflicting information between guidelines and SmPC/PIL. Results: Prescribers were more likely than non-prescribers to feel comfortable discussing medication safety during pregnancy. Most prescribers found clinical guidance documents useful, with 48% rating them as “very useful” and 38% as “extremely useful.” In case of conflicting information between clinical guidance documents and SmPC/PIL, 58% of HCPs reported that it caused confusion and tension in patient–doctor relationships, and almost 20% of them are “likely” or “very likely” to discontinue ongoing treatment. Clear communication and shared decision-making were the most common strategies used to address patient concerns. Conclusion: HCPs often face significant challenges when advising patients with RMDs on the use of medications during pregnancy and breastfeeding. Conflicting information between clinical guidance documents and SmPC/PIL can disrupt patient–doctor relationship and lead to treatment discontinuation, with potential consequences on maternal disease control. Improved alignment between clinical guidance documents and the SmPC/PIL could enhance patient care and prevent confusion among HCPs and patients.https://doi.org/10.1177/1759720X251350087 |
| spellingShingle | Karen Schreiber Christine Graversgaard Ioannis Parodis Nancy Agmon-Levin Silvia Aguilera Aleksandra Antovic George K. Bertsias Ilaria Bini Anca Bobirca Susana Capela Ricard Cervera Nathalie Costedoat-Chalumeau Radboud Dolhain Oseme Etomi Julia Flint Joao Eurico Fonseca Ruth Fritsch-Stork Frauke Förger Ian Giles Bethan Goulden Carina Götestam Skorpen Iva Gunnarsson Latika Gupta Hege Svean Koksvik Louise Linde Jacob Lykke Yvette Meissner Anna Molto Louise Moore Marta Mosca Catherine Nelson-Piercy Luis Fernando Perez-Garcia Luigi Raio Ane Lilleoere Rom Amihai Rottenstreich Muna Saleh Savino Sciascia Anja Strangfeld Elisabet Svenungsson Maria G. Tektonidou Angela Tincani Anne Troldborg Jelena Vojinovic Anne Voss Marianne Wallenius Nuria Zuniga-Serrano Laura Andreoli Impact of conflicting information on the use of antirheumatic drugs in pregnancy and breastfeeding: perspectives of healthcare providers from the global PRAISE survey Therapeutic Advances in Musculoskeletal Disease |
| title | Impact of conflicting information on the use of antirheumatic drugs in pregnancy and breastfeeding: perspectives of healthcare providers from the global PRAISE survey |
| title_full | Impact of conflicting information on the use of antirheumatic drugs in pregnancy and breastfeeding: perspectives of healthcare providers from the global PRAISE survey |
| title_fullStr | Impact of conflicting information on the use of antirheumatic drugs in pregnancy and breastfeeding: perspectives of healthcare providers from the global PRAISE survey |
| title_full_unstemmed | Impact of conflicting information on the use of antirheumatic drugs in pregnancy and breastfeeding: perspectives of healthcare providers from the global PRAISE survey |
| title_short | Impact of conflicting information on the use of antirheumatic drugs in pregnancy and breastfeeding: perspectives of healthcare providers from the global PRAISE survey |
| title_sort | impact of conflicting information on the use of antirheumatic drugs in pregnancy and breastfeeding perspectives of healthcare providers from the global praise survey |
| url | https://doi.org/10.1177/1759720X251350087 |
| work_keys_str_mv | AT karenschreiber impactofconflictinginformationontheuseofantirheumaticdrugsinpregnancyandbreastfeedingperspectivesofhealthcareprovidersfromtheglobalpraisesurvey AT christinegraversgaard impactofconflictinginformationontheuseofantirheumaticdrugsinpregnancyandbreastfeedingperspectivesofhealthcareprovidersfromtheglobalpraisesurvey AT ioannisparodis impactofconflictinginformationontheuseofantirheumaticdrugsinpregnancyandbreastfeedingperspectivesofhealthcareprovidersfromtheglobalpraisesurvey AT nancyagmonlevin impactofconflictinginformationontheuseofantirheumaticdrugsinpregnancyandbreastfeedingperspectivesofhealthcareprovidersfromtheglobalpraisesurvey AT silviaaguilera impactofconflictinginformationontheuseofantirheumaticdrugsinpregnancyandbreastfeedingperspectivesofhealthcareprovidersfromtheglobalpraisesurvey AT aleksandraantovic impactofconflictinginformationontheuseofantirheumaticdrugsinpregnancyandbreastfeedingperspectivesofhealthcareprovidersfromtheglobalpraisesurvey AT georgekbertsias impactofconflictinginformationontheuseofantirheumaticdrugsinpregnancyandbreastfeedingperspectivesofhealthcareprovidersfromtheglobalpraisesurvey AT ilariabini impactofconflictinginformationontheuseofantirheumaticdrugsinpregnancyandbreastfeedingperspectivesofhealthcareprovidersfromtheglobalpraisesurvey AT ancabobirca impactofconflictinginformationontheuseofantirheumaticdrugsinpregnancyandbreastfeedingperspectivesofhealthcareprovidersfromtheglobalpraisesurvey AT susanacapela impactofconflictinginformationontheuseofantirheumaticdrugsinpregnancyandbreastfeedingperspectivesofhealthcareprovidersfromtheglobalpraisesurvey AT ricardcervera impactofconflictinginformationontheuseofantirheumaticdrugsinpregnancyandbreastfeedingperspectivesofhealthcareprovidersfromtheglobalpraisesurvey AT nathaliecostedoatchalumeau impactofconflictinginformationontheuseofantirheumaticdrugsinpregnancyandbreastfeedingperspectivesofhealthcareprovidersfromtheglobalpraisesurvey AT radbouddolhain impactofconflictinginformationontheuseofantirheumaticdrugsinpregnancyandbreastfeedingperspectivesofhealthcareprovidersfromtheglobalpraisesurvey AT osemeetomi impactofconflictinginformationontheuseofantirheumaticdrugsinpregnancyandbreastfeedingperspectivesofhealthcareprovidersfromtheglobalpraisesurvey AT juliaflint impactofconflictinginformationontheuseofantirheumaticdrugsinpregnancyandbreastfeedingperspectivesofhealthcareprovidersfromtheglobalpraisesurvey AT joaoeuricofonseca impactofconflictinginformationontheuseofantirheumaticdrugsinpregnancyandbreastfeedingperspectivesofhealthcareprovidersfromtheglobalpraisesurvey AT ruthfritschstork impactofconflictinginformationontheuseofantirheumaticdrugsinpregnancyandbreastfeedingperspectivesofhealthcareprovidersfromtheglobalpraisesurvey AT fraukeforger impactofconflictinginformationontheuseofantirheumaticdrugsinpregnancyandbreastfeedingperspectivesofhealthcareprovidersfromtheglobalpraisesurvey AT iangiles impactofconflictinginformationontheuseofantirheumaticdrugsinpregnancyandbreastfeedingperspectivesofhealthcareprovidersfromtheglobalpraisesurvey AT bethangoulden impactofconflictinginformationontheuseofantirheumaticdrugsinpregnancyandbreastfeedingperspectivesofhealthcareprovidersfromtheglobalpraisesurvey AT carinagotestamskorpen impactofconflictinginformationontheuseofantirheumaticdrugsinpregnancyandbreastfeedingperspectivesofhealthcareprovidersfromtheglobalpraisesurvey AT ivagunnarsson impactofconflictinginformationontheuseofantirheumaticdrugsinpregnancyandbreastfeedingperspectivesofhealthcareprovidersfromtheglobalpraisesurvey AT latikagupta impactofconflictinginformationontheuseofantirheumaticdrugsinpregnancyandbreastfeedingperspectivesofhealthcareprovidersfromtheglobalpraisesurvey AT hegesveankoksvik impactofconflictinginformationontheuseofantirheumaticdrugsinpregnancyandbreastfeedingperspectivesofhealthcareprovidersfromtheglobalpraisesurvey AT louiselinde impactofconflictinginformationontheuseofantirheumaticdrugsinpregnancyandbreastfeedingperspectivesofhealthcareprovidersfromtheglobalpraisesurvey AT jacoblykke impactofconflictinginformationontheuseofantirheumaticdrugsinpregnancyandbreastfeedingperspectivesofhealthcareprovidersfromtheglobalpraisesurvey AT yvettemeissner impactofconflictinginformationontheuseofantirheumaticdrugsinpregnancyandbreastfeedingperspectivesofhealthcareprovidersfromtheglobalpraisesurvey AT annamolto impactofconflictinginformationontheuseofantirheumaticdrugsinpregnancyandbreastfeedingperspectivesofhealthcareprovidersfromtheglobalpraisesurvey AT louisemoore impactofconflictinginformationontheuseofantirheumaticdrugsinpregnancyandbreastfeedingperspectivesofhealthcareprovidersfromtheglobalpraisesurvey AT martamosca impactofconflictinginformationontheuseofantirheumaticdrugsinpregnancyandbreastfeedingperspectivesofhealthcareprovidersfromtheglobalpraisesurvey AT catherinenelsonpiercy impactofconflictinginformationontheuseofantirheumaticdrugsinpregnancyandbreastfeedingperspectivesofhealthcareprovidersfromtheglobalpraisesurvey AT luisfernandoperezgarcia impactofconflictinginformationontheuseofantirheumaticdrugsinpregnancyandbreastfeedingperspectivesofhealthcareprovidersfromtheglobalpraisesurvey AT luigiraio impactofconflictinginformationontheuseofantirheumaticdrugsinpregnancyandbreastfeedingperspectivesofhealthcareprovidersfromtheglobalpraisesurvey AT anelilleoererom impactofconflictinginformationontheuseofantirheumaticdrugsinpregnancyandbreastfeedingperspectivesofhealthcareprovidersfromtheglobalpraisesurvey AT amihairottenstreich impactofconflictinginformationontheuseofantirheumaticdrugsinpregnancyandbreastfeedingperspectivesofhealthcareprovidersfromtheglobalpraisesurvey AT munasaleh impactofconflictinginformationontheuseofantirheumaticdrugsinpregnancyandbreastfeedingperspectivesofhealthcareprovidersfromtheglobalpraisesurvey AT savinosciascia impactofconflictinginformationontheuseofantirheumaticdrugsinpregnancyandbreastfeedingperspectivesofhealthcareprovidersfromtheglobalpraisesurvey AT anjastrangfeld impactofconflictinginformationontheuseofantirheumaticdrugsinpregnancyandbreastfeedingperspectivesofhealthcareprovidersfromtheglobalpraisesurvey AT elisabetsvenungsson impactofconflictinginformationontheuseofantirheumaticdrugsinpregnancyandbreastfeedingperspectivesofhealthcareprovidersfromtheglobalpraisesurvey AT mariagtektonidou impactofconflictinginformationontheuseofantirheumaticdrugsinpregnancyandbreastfeedingperspectivesofhealthcareprovidersfromtheglobalpraisesurvey AT angelatincani impactofconflictinginformationontheuseofantirheumaticdrugsinpregnancyandbreastfeedingperspectivesofhealthcareprovidersfromtheglobalpraisesurvey AT annetroldborg impactofconflictinginformationontheuseofantirheumaticdrugsinpregnancyandbreastfeedingperspectivesofhealthcareprovidersfromtheglobalpraisesurvey AT jelenavojinovic impactofconflictinginformationontheuseofantirheumaticdrugsinpregnancyandbreastfeedingperspectivesofhealthcareprovidersfromtheglobalpraisesurvey AT annevoss impactofconflictinginformationontheuseofantirheumaticdrugsinpregnancyandbreastfeedingperspectivesofhealthcareprovidersfromtheglobalpraisesurvey AT mariannewallenius impactofconflictinginformationontheuseofantirheumaticdrugsinpregnancyandbreastfeedingperspectivesofhealthcareprovidersfromtheglobalpraisesurvey AT nuriazunigaserrano impactofconflictinginformationontheuseofantirheumaticdrugsinpregnancyandbreastfeedingperspectivesofhealthcareprovidersfromtheglobalpraisesurvey AT lauraandreoli impactofconflictinginformationontheuseofantirheumaticdrugsinpregnancyandbreastfeedingperspectivesofhealthcareprovidersfromtheglobalpraisesurvey |